No , there are no GLP-1 drops or oral solutions that have been approved for weight loss in the UK
The tier 3 programme is delivered by a multidisciplinary team including specialist weight management dietitians, physiotherapists, psychologists and obesity physicians over one year [22]
GLP-1 drugs like Ozempic and Wegovy have been associated with severe complications in some patients, including vision loss, NAION, and certain medically documented gastrointestinal injuries such as gastroparesis
NICE guidelines (NG28) recommend GLP-1 agonists as second- or third-line therapy for type 2 diabetes when metformin and other agents are insufficient or unsuitable
American Board of Anesthesiology (ABA) This activity offers up to 1.25 CME credits, of which 1.25 credits contribute the patient safety CME component of the American Board of Anesthesiologys redesigned Maintenance of Certification in Anesthesiology TM (MOCA) program, known as MOCA 2.0
Remarkably, there is evidence that GLP-1 agonists can enhance left ventricular ejection fraction, inotropy, coronary blood flow, cardiac output, and vascular endothelial function because of their cardiovascular effects and decrease overall cardiovascular event risks